Analysis of Serum Cytokine Profile in Pemphigus
Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized. This study was conducted to observe alterations in the serum cytoki...
Saved in:
| Published in | Annals of dermatology Vol. 29; no. 4; pp. 438 - 445 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
01.08.2017
대한피부과학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1013-9087 2005-3894 |
| DOI | 10.5021/ad.2017.29.4.438 |
Cover
Loading…
| Abstract | Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized.
This study was conducted to observe alterations in the serum cytokine levels of patients with pemphigus vulgaris (PV), pemphigus foliaceous (PF), paraneoplastic pemphigus (PNP) and compare with bullous pemphigoid (BP) and healthy subjects.
A total of 75 subjects (28 PV, 13 PF, 7 PNP, 7 BP, and 20 healthy controls) were included, all patients in active disease state. Serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-17A, IL-10, tumor necrosis factor (TNF)-α, and IL-8 were measured by enzyme-linked immunosorbent assay.
The median concentration of IFN-γ was lower in PV and BP patients compared to control (0.77, 0.34 and 1.63 pg/ml, respectively). IL-6 and IL-10 was significantly higher in PNP patients compared to control (4.92 and 0.24 pg/ml for IL-6, 0.86 and <0.12 pg/ml for IL-10, respectively). IL-8 was increased significantly in PV and PNP patients compared with control (11.85, 31.5 and 8.31 pg/ml, respectively). For IL-4, IL-17A and TNF-α, no significant difference was observed between the five groups.
The decreased level of IFN-γ in PV may imply suppressed Th1 response in the active disease stage. A Th2 predominant response is suggested in the active stage of PNP, with elevated serum levels of IL-6 and IL-10. Increased level of proinflammatory cytokine IL-8 is observed in the sera of PV and PNP patients. |
|---|---|
| AbstractList | Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized.
This study was conducted to observe alterations in the serum cytokine levels of patients with pemphigus vulgaris (PV), pemphigus foliaceous (PF), paraneoplastic pemphigus (PNP) and compare with bullous pemphigoid (BP) and healthy subjects.
A total of 75 subjects (28 PV, 13 PF, 7 PNP, 7 BP, and 20 healthy controls) were included, all patients in active disease state. Serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-17A, IL-10, tumor necrosis factor (TNF)-α, and IL-8 were measured by enzyme-linked immunosorbent assay.
The median concentration of IFN-γ was lower in PV and BP patients compared to control (0.77, 0.34 and 1.63 pg/ml, respectively). IL-6 and IL-10 was significantly higher in PNP patients compared to control (4.92 and 0.24 pg/ml for IL-6, 0.86 and <0.12 pg/ml for IL-10, respectively). IL-8 was increased significantly in PV and PNP patients compared with control (11.85, 31.5 and 8.31 pg/ml, respectively). For IL-4, IL-17A and TNF-α, no significant difference was observed between the five groups.
The decreased level of IFN-γ in PV may imply suppressed Th1 response in the active disease stage. A Th2 predominant response is suggested in the active stage of PNP, with elevated serum levels of IL-6 and IL-10. Increased level of proinflammatory cytokine IL-8 is observed in the sera of PV and PNP patients. Background: Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized. Objective: This study was conducted to observe alterations in the serum cytokine levels of patients with pemphigus vulgaris (PV), pemphigus foliaceous (PF), paraneoplastic pemphigus (PNP) and compare with bullous pemphigoid (BP) and healthy subjects. Methods: A total of 75 subjects (28 PV, 13 PF, 7 PNP, 7 BP, and 20 healthy controls) were included, all patients in active disease state. Serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-17A, IL-10, tumor necrosis factor (TNF)-α, and IL-8 were measured by enzyme-linked immunosorbent assay. Results: The median concentration of IFN-γ was lower in PV and BP patients compared to control (0.77, 0.34 and 1.63 pg/ml, respectively). IL-6 and IL-10 was significantly higher in PNP patients compared to control (4.92 and 0.24 pg/ml for IL-6, 0.86 and ＜0.12 pg/ml for IL-10, respectively). IL-8 was increased significantly in PV and PNP patients compared with control (11.85, 31.5 and 8.31 pg/ml, respectively). For IL-4, IL-17A and TNF-α, no significant difference was observed between the five groups. Conclusion: The decreased level of IFN-γ in PV may imply suppressed Th1 response in the active disease stage. A Th2 predominant response is suggested in the active stage of PNP, with elevated serum levels of IL-6 and IL-10. Increased level of proinflammatory cytokine IL-8 is observed in the sera of PV and PNP patients. KCI Citation Count: 8 Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized.BACKGROUNDPemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T cells and cytokines in the pathogenesis is being increasingly recognized.This study was conducted to observe alterations in the serum cytokine levels of patients with pemphigus vulgaris (PV), pemphigus foliaceous (PF), paraneoplastic pemphigus (PNP) and compare with bullous pemphigoid (BP) and healthy subjects.OBJECTIVEThis study was conducted to observe alterations in the serum cytokine levels of patients with pemphigus vulgaris (PV), pemphigus foliaceous (PF), paraneoplastic pemphigus (PNP) and compare with bullous pemphigoid (BP) and healthy subjects.A total of 75 subjects (28 PV, 13 PF, 7 PNP, 7 BP, and 20 healthy controls) were included, all patients in active disease state. Serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-17A, IL-10, tumor necrosis factor (TNF)-α, and IL-8 were measured by enzyme-linked immunosorbent assay.METHODSA total of 75 subjects (28 PV, 13 PF, 7 PNP, 7 BP, and 20 healthy controls) were included, all patients in active disease state. Serum levels of interferon (IFN)-γ, interleukin (IL)-4, IL-6, IL-17A, IL-10, tumor necrosis factor (TNF)-α, and IL-8 were measured by enzyme-linked immunosorbent assay.The median concentration of IFN-γ was lower in PV and BP patients compared to control (0.77, 0.34 and 1.63 pg/ml, respectively). IL-6 and IL-10 was significantly higher in PNP patients compared to control (4.92 and 0.24 pg/ml for IL-6, 0.86 and <0.12 pg/ml for IL-10, respectively). IL-8 was increased significantly in PV and PNP patients compared with control (11.85, 31.5 and 8.31 pg/ml, respectively). For IL-4, IL-17A and TNF-α, no significant difference was observed between the five groups.RESULTSThe median concentration of IFN-γ was lower in PV and BP patients compared to control (0.77, 0.34 and 1.63 pg/ml, respectively). IL-6 and IL-10 was significantly higher in PNP patients compared to control (4.92 and 0.24 pg/ml for IL-6, 0.86 and <0.12 pg/ml for IL-10, respectively). IL-8 was increased significantly in PV and PNP patients compared with control (11.85, 31.5 and 8.31 pg/ml, respectively). For IL-4, IL-17A and TNF-α, no significant difference was observed between the five groups.The decreased level of IFN-γ in PV may imply suppressed Th1 response in the active disease stage. A Th2 predominant response is suggested in the active stage of PNP, with elevated serum levels of IL-6 and IL-10. Increased level of proinflammatory cytokine IL-8 is observed in the sera of PV and PNP patients.CONCLUSIONThe decreased level of IFN-γ in PV may imply suppressed Th1 response in the active disease stage. A Th2 predominant response is suggested in the active stage of PNP, with elevated serum levels of IL-6 and IL-10. Increased level of proinflammatory cytokine IL-8 is observed in the sera of PV and PNP patients. |
| Author | Hong, Won Jin Kim, Soo-Chan Lee, Sang Hee |
| AuthorAffiliation | Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| AuthorAffiliation_xml | – name: Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| Author_xml | – sequence: 1 givenname: Sang Hee surname: Lee fullname: Lee, Sang Hee organization: Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea – sequence: 2 givenname: Won Jin surname: Hong fullname: Hong, Won Jin organization: Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea – sequence: 3 givenname: Soo-Chan surname: Kim fullname: Kim, Soo-Chan organization: Department of Dermatology and Cutaneous Biology Research Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28761292$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002246520$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1kc1r3DAQxUVJaDZJ7z0VH9uDndGXJV0Ky9I2gUBDsnehSHKirm1tJbuw_3212SS0hZ5mYH7vPaR3io7GOHqE3mNoOBB8YVxDAIuGqIY1jMo3aEEAeE2lYkdogQHTWoEUJ-g05x8ALSYCv0UnRIqyKrJAF8vR9LscchW76s6neahWuyluwuirmxS70PsqjNWNH7aP4WHO5-i4M332757nGVp__bJeXdbX379drZbXtWUUpto6TqTnTkhmS5bgimAGHXaO0lYqbKmjmDjqlJQEvGBC0RbblnF2zzpDz9Cng-2YOr2xQUcTnuZD1Jukl7frK40Zplzwwn4-sNv5fvDO-nFKptfbFAaTdk_Kvy9jeCw-vzTnAAJUMfj4bJDiz9nnSQ8hW9_3ZvRxzhorUl4joRUF_fBn1mvIy4cWoD0ANsWck--0DZOZQtxHh15j0PvmtHF635wmSjNdmitC-Ef44v1fyW9fLJju |
| CitedBy_id | crossref_primary_10_1111_jdv_20423 crossref_primary_10_3389_fimmu_2024_1500284 crossref_primary_10_4103_ejdv_ejdv_7_21 crossref_primary_10_1007_s12026_020_09122_y crossref_primary_10_7759_cureus_29890 crossref_primary_10_1111_exd_15173 crossref_primary_10_1080_17512433_2024_2350943 crossref_primary_10_1016_j_autrev_2020_102661 crossref_primary_10_1111_cup_14115 crossref_primary_10_7759_cureus_54610 crossref_primary_10_1111_dth_14605 crossref_primary_10_1111_jocd_14945 crossref_primary_10_3389_fimmu_2024_1343299 crossref_primary_10_3389_fimmu_2019_01089 crossref_primary_10_3389_fimmu_2019_00770 crossref_primary_10_1007_s00105_023_05246_y crossref_primary_10_1177_1559325819850984 crossref_primary_10_17816_dv636920 crossref_primary_10_3389_fimmu_2023_1220887 crossref_primary_10_3390_ijms24010323 crossref_primary_10_1016_j_jaut_2024_103261 crossref_primary_10_3389_fimmu_2018_00695 crossref_primary_10_1016_j_autrev_2019_03_009 crossref_primary_10_1159_000512916 crossref_primary_10_1111_1346_8138_16663 crossref_primary_10_1111_1346_8138_14789 crossref_primary_10_3389_fimmu_2024_1500231 crossref_primary_10_1111_dth_14353 crossref_primary_10_1007_s00403_022_02346_y crossref_primary_10_1111_cup_13312 crossref_primary_10_1111_vde_12949 crossref_primary_10_56951_medicinus_v34i3_79 crossref_primary_10_17816_dv633413 crossref_primary_10_3389_fimmu_2019_01259 crossref_primary_10_1001_jamadermatol_2021_4055 crossref_primary_10_1002_ccr3_6998 crossref_primary_10_3389_fmolb_2021_808536 crossref_primary_10_17816_dv492306 crossref_primary_10_61186_jrdms_8_4_286 crossref_primary_10_1016_j_cyto_2020_155026 crossref_primary_10_4103_idoj_idoj_38_23 crossref_primary_10_1016_j_jaad_2020_06_037 crossref_primary_10_1111_dth_14482 |
| Cites_doi | 10.1111/j.1365-2230.2005.01836.x 10.1016/j.jdermsci.2008.09.008 10.1016/S0190-9622(99)70145-3 10.1046/j.1365-2249.2000.01104.x 10.1111/j.1365-2133.2005.06672.x 10.4049/jimmunol.172.10.6468 10.1046/j.1365-2133.2000.03599.x 10.1001/archdermatol.2010.409 10.1046/j.1523-1747.2000.00835.x 10.1016/S0092-8674(00)80240-8 10.1159/000056375 10.3109/08916934.2012.697593 10.1006/cyto.1999.0642 10.1111/j.1346-8138.2012.01655.x 10.1046/j.1523-1747.1999.00520.x 10.1046/j.1365-4362.2001.01083.x 10.1615/CritRevImmunol.v32.i1.30 10.1111/j.0105-1873.2006.00848.x 10.1172/JCI119130 10.1159/000247496 10.5021/ad.2015.27.2.163 10.1056/NEJM199012203232503 10.1111/bjd.13350 10.1038/cmi.2012.60 10.1182/blood.V74.2.798.798 10.4049/jimmunol.182.3.1740 10.1111/1523-1747.ep12292156 10.1016/j.cyto.2014.11.002 10.1177/120347549900300306 10.4049/jimmunol.170.1.635 10.1046/j.1523-1747.2000.00840.x 10.4049/jimmunol.167.2.724 10.4049/jimmunol.181.2.1526 10.1016/S0923-1811(02)00067-1 10.1111/j.1468-3083.2008.02929.x 10.1159/000063895 10.2340/00015555-0683 10.1046/j.1523-1747.1998.00086.x 10.1016/j.cyto.2007.12.007 10.1080/08820130902943097 10.1038/ni0407-345 |
| ContentType | Journal Article |
| Copyright | Copyright © 2017 The Korean Dermatological Association and The Korean Society for Investigative Dermatology 2017 |
| Copyright_xml | – notice: Copyright © 2017 The Korean Dermatological Association and The Korean Society for Investigative Dermatology 2017 |
| DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.5021/ad.2017.29.4.438 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2005-3894 |
| EndPage | 445 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_1413575 PMC5500709 28761292 10_5021_ad_2017_29_4_438 |
| Genre | Journal Article |
| GroupedDBID | 23M 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL C1A CITATION DIK E3Z EF. F5P HYE HZB MZR OK1 RPM TR2 ZZE M~E NPM 7X8 85H 5PM |
| ID | FETCH-LOGICAL-c430t-cd528e5d784c8767592140f1dd336891c3d312d3d98820e7479361c6454b4fa3 |
| ISSN | 1013-9087 |
| IngestDate | Sun Mar 09 07:54:46 EDT 2025 Thu Aug 21 14:09:11 EDT 2025 Fri Sep 05 08:16:57 EDT 2025 Thu Jan 02 22:42:20 EST 2025 Tue Jul 01 02:57:12 EDT 2025 Thu Apr 24 23:07:14 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Autoimmunity Cytokines Pemphigus |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c430t-cd528e5d784c8767592140f1dd336891c3d312d3d98820e7479361c6454b4fa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5500709 |
| PMID | 28761292 |
| PQID | 1925288067 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1413575 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5500709 proquest_miscellaneous_1925288067 pubmed_primary_28761292 crossref_citationtrail_10_5021_ad_2017_29_4_438 crossref_primary_10_5021_ad_2017_29_4_438 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-08-01 |
| PublicationDateYYYYMMDD | 2017-08-01 |
| PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Annals of dermatology |
| PublicationTitleAlternate | Ann Dermatol |
| PublicationYear | 2017 |
| Publisher | The Korean Dermatological Association; The Korean Society for Investigative Dermatology 대한피부과학회 |
| Publisher_xml | – name: The Korean Dermatological Association; The Korean Society for Investigative Dermatology – name: 대한피부과학회 |
| References | Alecu (10.5021/ad.2017.29.4.438_ref8) 1999; 58 Feliciani (10.5021/ad.2017.29.4.438_ref10) 1999; 3 Kaneko (10.5021/ad.2017.29.4.438_ref23) 1992; 184 Veldman (10.5021/ad.2017.29.4.438_ref21) 2003; 170 Daulat (10.5021/ad.2017.29.4.438_ref41) 2009; 23 Feliciani (10.5021/ad.2017.29.4.438_ref11) 2000; 114 Robinson (10.5021/ad.2017.29.4.438_ref2) 1999; 40 Sjögren (10.5021/ad.2017.29.4.438_ref36) 2009; 89 Choi (10.5021/ad.2017.29.4.438_ref14) 2012; 39 Wakugawa (10.5021/ad.2017.29.4.438_ref24) 2000; 143 Takahashi (10.5021/ad.2017.29.4.438_ref17) 2008; 181 Zheng (10.5021/ad.2017.29.4.438_ref19) 1997; 89 Hall (10.5021/ad.2017.29.4.438_ref43) 2015; 172 Hertl (10.5021/ad.2017.29.4.438_ref20) 1998; 110 Bhol (10.5021/ad.2017.29.4.438_ref25) 2000; 12 Anhalt (10.5021/ad.2017.29.4.438_ref3) 1990; 323 Satyam (10.5021/ad.2017.29.4.438_ref6) 2009; 38 Keskin (10.5021/ad.2017.29.4.438_ref13) 2008; 41 Veldman (10.5021/ad.2017.29.4.438_ref29) 2004; 172 Bettelli (10.5021/ad.2017.29.4.438_ref28) 2007; 8 Iyer (10.5021/ad.2017.29.4.438_ref30) 2012; 32 Nishifuji (10.5021/ad.2017.29.4.438_ref16) 2000; 114 D'Auria (10.5021/ad.2017.29.4.438_ref15) 1997; 8 Yang (10.5021/ad.2017.29.4.438_ref32) 2013; 10 Hertl (10.5021/ad.2017.29.4.438_ref1) 2001; 14 Pardo (10.5021/ad.2017.29.4.438_ref40) 2005; 153 Nousari (10.5021/ad.2017.29.4.438_ref33) 1999; 112 Lin (10.5021/ad.2017.29.4.438_ref22) 1997; 99 Baroni (10.5021/ad.2017.29.4.438_ref12) 2002; 205 O'Toole (10.5021/ad.2017.29.4.438_ref35) 2000; 119 Giordano (10.5021/ad.2017.29.4.438_ref5) 2012; 45 De Jongh (10.5021/ad.2017.29.4.438_ref37) 2006; 54 Fiorentino (10.5021/ad.2017.29.4.438_ref42) 2011; 147 Takahashi (10.5021/ad.2017.29.4.438_ref4) 2009; 182 Nawijn (10.5021/ad.2017.29.4.438_ref18) 2001; 167 Lee (10.5021/ad.2017.29.4.438_ref39) 2015; 27 Giomi (10.5021/ad.2017.29.4.438_ref26) 2002; 30 López-Robles (10.5021/ad.2017.29.4.438_ref9) 2001; 40 Rizzo (10.5021/ad.2017.29.4.438_ref27) 2005; 30 Cho (10.5021/ad.2017.29.4.438_ref31) 2015; 73 Yee (10.5021/ad.2017.29.4.438_ref34) 1989; 74 Strickland (10.5021/ad.2017.29.4.438_ref38) 1997; 108 Arakawa (10.5021/ad.2017.29.4.438_ref7) 2009; 53 9011573 - J Clin Invest. 1997 Jan 1;99(1):31-40 10620121 - J Invest Dermatol. 2000 Jan;114(1):88-94 9129230 - J Invest Dermatol. 1997 May;108(5):763-8 10880254 - Cytokine. 2000 Jul;12(7):1076-83 12496453 - J Immunol. 2003 Jan 1;170(1):635-42 16787454 - Contact Dermatitis. 2006 Jun;54(6):325-33 16045688 - Clin Exp Dermatol. 2005 Sep;30(5):535-40 22428854 - Crit Rev Immunol. 2012;32(1):23-63 18793242 - J Eur Acad Dermatol Venereol. 2009 Apr;23(4):483-4 18606708 - J Immunol. 2008 Jul 15;181(2):1526-35 19811408 - Immunol Invest. 2009;38(6):498-509 10321591 - J Am Acad Dermatol. 1999 May;40(5 Pt 1):649-71; quiz 672-3 12413767 - J Dermatol Sci. 2002 Nov;30(2):116-28 10886144 - Br J Dermatol. 2000 Jul;143(1):112-6 18980832 - J Dermatol Sci. 2009 Mar;53(3):228-31 1558993 - Dermatology. 1992;184(1):34-9 12218224 - Dermatology. 2002;205(2):116-21 11441076 - J Immunol. 2001 Jul 15;167(2):724-32 25834355 - Ann Dermatol. 2015 Apr;27(2):163-70 10082594 - J Cutan Med Surg. 1999 Jan;3(3):140-4 25464924 - Cytokine. 2015 Jun;73(2):335-41 21242406 - Arch Dermatol. 2011 Jan;147(1):117-8 16029365 - Br J Dermatol. 2005 Jul;153(1):222-3 23292280 - Cell Mol Immunol. 2013 Mar;10(2):122-32 9459618 - Eur Cytokine Netw. 1997 Dec;8(4):383-7 18289869 - Cytokine. 2008 Mar;41(3):315-21 9160750 - Cell. 1997 May 16;89(4):587-96 10606986 - Clin Exp Immunol. 2000 Jan;119(1):217-24 25123295 - Br J Dermatol. 2015 Mar;172(3):760-8 10620118 - J Invest Dermatol. 2000 Jan;114(1):71-7 15128839 - J Immunol. 2004 May 15;172(10):6468-75 2247105 - N Engl J Med. 1990 Dec 20;323(25):1729-35 10084324 - J Invest Dermatol. 1999 Mar;112(3):396-8 19734969 - Acta Derm Venereol. 2009;89(5):459-65 2787680 - Blood. 1989 Aug 1;74(2):798-804 11845451 - Roum Arch Microbiol Immunol. 1999 Apr-Jul;58(2):121-30 17375096 - Nat Immunol. 2007 Apr;8(4):345-50 11598441 - Skin Pharmacol Appl Skin Physiol. 2001 Nov-Dec;14(6):408-18 22686612 - Autoimmunity. 2012 Sep;45(6):427-39 19155523 - J Immunol. 2009 Feb 1;182(3):1740-5 22938021 - J Dermatol. 2012 Dec;39(12):973-81 9424089 - J Invest Dermatol. 1998 Jan;110(1):62-6 11422521 - Int J Dermatol. 2001 Mar;40(3):185-8 |
| References_xml | – volume: 30 start-page: 535 year: 2005 ident: 10.5021/ad.2017.29.4.438_ref27 publication-title: Clin Exp Dermatol doi: 10.1111/j.1365-2230.2005.01836.x – volume: 8 start-page: 383 year: 1997 ident: 10.5021/ad.2017.29.4.438_ref15 publication-title: Eur Cytokine Netw – volume: 53 start-page: 228 year: 2009 ident: 10.5021/ad.2017.29.4.438_ref7 publication-title: J Dermatol Sci doi: 10.1016/j.jdermsci.2008.09.008 – volume: 40 start-page: 649 year: 1999 ident: 10.5021/ad.2017.29.4.438_ref2 publication-title: J Am Acad Dermatol doi: 10.1016/S0190-9622(99)70145-3 – volume: 119 start-page: 217 year: 2000 ident: 10.5021/ad.2017.29.4.438_ref35 publication-title: Clin Exp Immunol doi: 10.1046/j.1365-2249.2000.01104.x – volume: 153 start-page: 222 year: 2005 ident: 10.5021/ad.2017.29.4.438_ref40 publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2005.06672.x – volume: 172 start-page: 6468 year: 2004 ident: 10.5021/ad.2017.29.4.438_ref29 publication-title: J Immunol doi: 10.4049/jimmunol.172.10.6468 – volume: 143 start-page: 112 year: 2000 ident: 10.5021/ad.2017.29.4.438_ref24 publication-title: Br J Dermatol doi: 10.1046/j.1365-2133.2000.03599.x – volume: 147 start-page: 117 year: 2011 ident: 10.5021/ad.2017.29.4.438_ref42 publication-title: Arch Dermatol doi: 10.1001/archdermatol.2010.409 – volume: 114 start-page: 71 year: 2000 ident: 10.5021/ad.2017.29.4.438_ref11 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2000.00835.x – volume: 89 start-page: 587 year: 1997 ident: 10.5021/ad.2017.29.4.438_ref19 publication-title: Cell doi: 10.1016/S0092-8674(00)80240-8 – volume: 14 start-page: 408 year: 2001 ident: 10.5021/ad.2017.29.4.438_ref1 publication-title: Skin Pharmacol Appl Skin Physiol doi: 10.1159/000056375 – volume: 45 start-page: 427 year: 2012 ident: 10.5021/ad.2017.29.4.438_ref5 publication-title: Autoimmunity doi: 10.3109/08916934.2012.697593 – volume: 12 start-page: 1076 year: 2000 ident: 10.5021/ad.2017.29.4.438_ref25 publication-title: Cytokine doi: 10.1006/cyto.1999.0642 – volume: 39 start-page: 973 year: 2012 ident: 10.5021/ad.2017.29.4.438_ref14 publication-title: J Dermatol doi: 10.1111/j.1346-8138.2012.01655.x – volume: 112 start-page: 396 year: 1999 ident: 10.5021/ad.2017.29.4.438_ref33 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.1999.00520.x – volume: 40 start-page: 185 year: 2001 ident: 10.5021/ad.2017.29.4.438_ref9 publication-title: Int J Dermatol doi: 10.1046/j.1365-4362.2001.01083.x – volume: 32 start-page: 23 year: 2012 ident: 10.5021/ad.2017.29.4.438_ref30 publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.v32.i1.30 – volume: 54 start-page: 325 year: 2006 ident: 10.5021/ad.2017.29.4.438_ref37 publication-title: Contact Dermatitis doi: 10.1111/j.0105-1873.2006.00848.x – volume: 99 start-page: 31 year: 1997 ident: 10.5021/ad.2017.29.4.438_ref22 publication-title: J Clin Invest doi: 10.1172/JCI119130 – volume: 184 start-page: 34 year: 1992 ident: 10.5021/ad.2017.29.4.438_ref23 publication-title: Dermatology doi: 10.1159/000247496 – volume: 27 start-page: 163 year: 2015 ident: 10.5021/ad.2017.29.4.438_ref39 publication-title: Ann Dermatol doi: 10.5021/ad.2015.27.2.163 – volume: 323 start-page: 1729 year: 1990 ident: 10.5021/ad.2017.29.4.438_ref3 publication-title: N Engl J Med doi: 10.1056/NEJM199012203232503 – volume: 172 start-page: 760 year: 2015 ident: 10.5021/ad.2017.29.4.438_ref43 publication-title: Br J Dermatol doi: 10.1111/bjd.13350 – volume: 10 start-page: 122 year: 2013 ident: 10.5021/ad.2017.29.4.438_ref32 publication-title: Cell Mol Immunol doi: 10.1038/cmi.2012.60 – volume: 74 start-page: 798 year: 1989 ident: 10.5021/ad.2017.29.4.438_ref34 publication-title: Blood doi: 10.1182/blood.V74.2.798.798 – volume: 182 start-page: 1740 year: 2009 ident: 10.5021/ad.2017.29.4.438_ref4 publication-title: J Immunol doi: 10.4049/jimmunol.182.3.1740 – volume: 108 start-page: 763 year: 1997 ident: 10.5021/ad.2017.29.4.438_ref38 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12292156 – volume: 73 start-page: 335 year: 2015 ident: 10.5021/ad.2017.29.4.438_ref31 publication-title: Cytokine doi: 10.1016/j.cyto.2014.11.002 – volume: 3 start-page: 140 year: 1999 ident: 10.5021/ad.2017.29.4.438_ref10 publication-title: J Cutan Med Surg doi: 10.1177/120347549900300306 – volume: 170 start-page: 635 year: 2003 ident: 10.5021/ad.2017.29.4.438_ref21 publication-title: J Immunol doi: 10.4049/jimmunol.170.1.635 – volume: 114 start-page: 88 year: 2000 ident: 10.5021/ad.2017.29.4.438_ref16 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2000.00840.x – volume: 167 start-page: 724 year: 2001 ident: 10.5021/ad.2017.29.4.438_ref18 publication-title: J Immunol doi: 10.4049/jimmunol.167.2.724 – volume: 181 start-page: 1526 year: 2008 ident: 10.5021/ad.2017.29.4.438_ref17 publication-title: J Immunol doi: 10.4049/jimmunol.181.2.1526 – volume: 30 start-page: 116 year: 2002 ident: 10.5021/ad.2017.29.4.438_ref26 publication-title: J Dermatol Sci doi: 10.1016/S0923-1811(02)00067-1 – volume: 23 start-page: 483 year: 2009 ident: 10.5021/ad.2017.29.4.438_ref41 publication-title: J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2008.02929.x – volume: 205 start-page: 116 year: 2002 ident: 10.5021/ad.2017.29.4.438_ref12 publication-title: Dermatology doi: 10.1159/000063895 – volume: 89 start-page: 459 year: 2009 ident: 10.5021/ad.2017.29.4.438_ref36 publication-title: Acta Derm Venereol doi: 10.2340/00015555-0683 – volume: 58 start-page: 121 year: 1999 ident: 10.5021/ad.2017.29.4.438_ref8 publication-title: Roum Arch Microbiol Immunol – volume: 110 start-page: 62 year: 1998 ident: 10.5021/ad.2017.29.4.438_ref20 publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.1998.00086.x – volume: 41 start-page: 315 year: 2008 ident: 10.5021/ad.2017.29.4.438_ref13 publication-title: Cytokine doi: 10.1016/j.cyto.2007.12.007 – volume: 38 start-page: 498 year: 2009 ident: 10.5021/ad.2017.29.4.438_ref6 publication-title: Immunol Invest doi: 10.1080/08820130902943097 – volume: 8 start-page: 345 year: 2007 ident: 10.5021/ad.2017.29.4.438_ref28 publication-title: Nat Immunol doi: 10.1038/ni0407-345 – reference: 18606708 - J Immunol. 2008 Jul 15;181(2):1526-35 – reference: 10880254 - Cytokine. 2000 Jul;12(7):1076-83 – reference: 19811408 - Immunol Invest. 2009;38(6):498-509 – reference: 10620121 - J Invest Dermatol. 2000 Jan;114(1):88-94 – reference: 11441076 - J Immunol. 2001 Jul 15;167(2):724-32 – reference: 11598441 - Skin Pharmacol Appl Skin Physiol. 2001 Nov-Dec;14(6):408-18 – reference: 18793242 - J Eur Acad Dermatol Venereol. 2009 Apr;23(4):483-4 – reference: 25464924 - Cytokine. 2015 Jun;73(2):335-41 – reference: 2247105 - N Engl J Med. 1990 Dec 20;323(25):1729-35 – reference: 19155523 - J Immunol. 2009 Feb 1;182(3):1740-5 – reference: 19734969 - Acta Derm Venereol. 2009;89(5):459-65 – reference: 23292280 - Cell Mol Immunol. 2013 Mar;10(2):122-32 – reference: 15128839 - J Immunol. 2004 May 15;172(10):6468-75 – reference: 10082594 - J Cutan Med Surg. 1999 Jan;3(3):140-4 – reference: 10321591 - J Am Acad Dermatol. 1999 May;40(5 Pt 1):649-71; quiz 672-3 – reference: 25834355 - Ann Dermatol. 2015 Apr;27(2):163-70 – reference: 9459618 - Eur Cytokine Netw. 1997 Dec;8(4):383-7 – reference: 16787454 - Contact Dermatitis. 2006 Jun;54(6):325-33 – reference: 9011573 - J Clin Invest. 1997 Jan 1;99(1):31-40 – reference: 11845451 - Roum Arch Microbiol Immunol. 1999 Apr-Jul;58(2):121-30 – reference: 10620118 - J Invest Dermatol. 2000 Jan;114(1):71-7 – reference: 1558993 - Dermatology. 1992;184(1):34-9 – reference: 2787680 - Blood. 1989 Aug 1;74(2):798-804 – reference: 18289869 - Cytokine. 2008 Mar;41(3):315-21 – reference: 10084324 - J Invest Dermatol. 1999 Mar;112(3):396-8 – reference: 9160750 - Cell. 1997 May 16;89(4):587-96 – reference: 9424089 - J Invest Dermatol. 1998 Jan;110(1):62-6 – reference: 21242406 - Arch Dermatol. 2011 Jan;147(1):117-8 – reference: 12496453 - J Immunol. 2003 Jan 1;170(1):635-42 – reference: 10886144 - Br J Dermatol. 2000 Jul;143(1):112-6 – reference: 16029365 - Br J Dermatol. 2005 Jul;153(1):222-3 – reference: 9129230 - J Invest Dermatol. 1997 May;108(5):763-8 – reference: 17375096 - Nat Immunol. 2007 Apr;8(4):345-50 – reference: 11422521 - Int J Dermatol. 2001 Mar;40(3):185-8 – reference: 22428854 - Crit Rev Immunol. 2012;32(1):23-63 – reference: 10606986 - Clin Exp Immunol. 2000 Jan;119(1):217-24 – reference: 16045688 - Clin Exp Dermatol. 2005 Sep;30(5):535-40 – reference: 22686612 - Autoimmunity. 2012 Sep;45(6):427-39 – reference: 22938021 - J Dermatol. 2012 Dec;39(12):973-81 – reference: 12218224 - Dermatology. 2002;205(2):116-21 – reference: 12413767 - J Dermatol Sci. 2002 Nov;30(2):116-28 – reference: 18980832 - J Dermatol Sci. 2009 Mar;53(3):228-31 – reference: 25123295 - Br J Dermatol. 2015 Mar;172(3):760-8 |
| SSID | ssj0061271 |
| Score | 2.2711732 |
| Snippet | Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T... Background: Pemphigus is a group of autoimmune blistering diseases affecting skin and mucous membranes. While pemphigus is an autoantibody mediated disease,... |
| SourceID | nrf pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 438 |
| SubjectTerms | Original 피부과학 |
| Title | Analysis of Serum Cytokine Profile in Pemphigus |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28761292 https://www.proquest.com/docview/1925288067 https://pubmed.ncbi.nlm.nih.gov/PMC5500709 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002246520 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Annals of Dermatology, 2017, 29(4), , pp.438-445 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXYkBAviG8CAwXEC0JpE8dpksdpAo1JQ5NWxN6s1Ha6qJCgkj6wX79zEydLykCMl7RyXefj3Pjec20fM_ZWKR3MdM69QAfcE5GOvESJhRfrGP4lIwkQGtE9_jw7_CKOzqKzbjd7u7qkXkzUxbXrSv4HVZQBV1olewNk-0ZRgO_AF0cgjOM_YTxUFMFLv_n-_uBXXa0ocDxp9-KmdMaJAWLF0jL834STNfXN9Si7bmfnnGblEn7pCno7ffcrLOaoGAzfNzZ1WlUerVUY5hHgm7pZbF3XR_s8pL51f6Ypa3RKEdKIYX9pMxTFMBnQdH6i1WnZ7pQjhBHkcUiXNYgnPJ2Iia061r_e8kv9bEHwFGpDZlpSC5KnUki0sMNuc5ADv8vRtP4XIVtLs7v7aQenqYXp9jWMgpGdcp1fxzO2p8sO4o_5fXbPEgd3v7WCB-yWKR-yO8d2asQjNu2Mwa1ytzEGtzMG1xqDW5RubwyP2fzjh_nBoWd3w_CUCP3aUzriiYl0nAiVkARPykGO80DrMJwlaaBCHQZchzoFafJNTCnTWaBIsW0h8ix8wnbLqjTPmItqkVF-zDNhhNY-hazcT4xC6BfmvnLYtHsqUlmleNqw5Jv8ExIOe9f_40erkvKXum_woOVKFZKkzelzWcnVWoLAfQITDUIwCIe97nCQ6O9oECsrTbX5KcFI8BwSBFkOe9ri0p8S7B_op9xh8QixvgKdcPxLWZw3muog6nB-6fMb3MgLdvfqPdpju_V6Y14iQq0XrxqDvAQvzIkB |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+Serum+Cytokine+Profile+in+Pemphigus&rft.jtitle=Annals+of+dermatology&rft.au=Lee%2C+Sang+Hee&rft.au=Hong%2C+Won+Jin&rft.au=Kim%2C+Soo-Chan&rft.date=2017-08-01&rft.issn=1013-9087&rft.eissn=2005-3894&rft.volume=29&rft.issue=4&rft.spage=438&rft_id=info:doi/10.5021%2Fad.2017.29.4.438&rft.externalDBID=n%2Fa&rft.externalDocID=10_5021_ad_2017_29_4_438 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1013-9087&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1013-9087&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1013-9087&client=summon |